NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


ADVERTISMENT

ADVERTISMENT

Gut bacteria are ‘crucial for liver repair’

By Irish Pharmacist - 03rd Apr 2023

German researchers have shed light on the important connection between liver repair and gut bacteria

When parts of the liver are removed, the body can replace the missing tissue. A team of researchers at the Technical University of Munich (TUM) has now discovered that the success of this process depends to a large extent on gut bacteria. The results of the study could help to improve the prognosis after liver surgery in case of liver cancer and other diseases, say the researchers.

The human liver has an astonishing ability to regenerate, unlike the heart, for example. The underlying biological mechanisms are an example of the role played by our gut bacteria in processes taking place in other organs. This is demonstrated in new research conducted by an interdisciplinary team from the TUM University Hospital Klinikum rechts der Isar and the TUM School of Life Sciences in Germany.

A healthy gut microbiome consists of many types of bacteria and they play an active role in digestion. Some of them break down carbohydrates into short-chain fatty acids (SCFAs), for example. “Liver cells need these fatty acids to grow and divide,” said study leader Prof Klaus-Peter Janssen from the Department of Surgery of the Klinikum rechts der Isar. “We have now succeeded in showing for the first time that gut bacteria influence the lipid metabolism in liver cells, and therefore their ability to regenerate.”

Disrupted microbiome

Prof Janssen and his team conducted experiments on mice to determine how a disrupted microbiome affects liver regeneration. In animals in which the microbiome was perturbed through antibiotics, formation of new liver cells was strongly delayed.

Scientists were already aware of a link between antibiotics and disrupted liver regeneration. However, this was previously attributed to the body’s immune response or harmful side-effects of antibiotics on liver cells, explains Prof Janssen. The mechanistic connection to gut bacteria only came to light in the TUM study. In accordance with mice treated with antibiotics, liver cells were also not regenerated in mice lacking a microbiome already at birth.

“Antibiotics do not kill all gut bacteria,” explained Anna Sichler, one of the two first authors of the study. “However, the medication changes the composition of the microbiome: The remaining bacteria species produce far fewer short-chain fatty acids.” The microbiome usually recovers within a few weeks of the antibiotic treatment. The current study showed that liver regeneration also occurred in animals treated with antibiotics, but with a significant delay. In mice lacking gut bacteria, no regeneration took place. However, the researchers were able to stimulate liver regeneration by treating them with a precisely defined “microbiome starter set”.

Using organoids made up of mouse cells — essentially miniature livers in a Petri dish — the researchers demonstrated that SCFAs provide essential building blocks for the cell membrane in liver cells. If SCFAs are not present in sufficient quantities, the cells refuse to grow and multiply. When the cells multiplied because enough fatty acids were available, the team found that an enzyme known as SCD1 was especially active. “We then investigated the processes with human liver cells and tissue samples,” said Yuhan Yin, who is also a first author of the study. “SCD1 is also active in humans when the liver regenerates.”

Applications

“It is important to bear in mind that the role of gut bacteria in our bodies is highly complex. We have a long way to go before we fully understand it,” said Prof Janssen. Therefore, the study does not offer specific recommendations for further action or the development of drugs. “However, our results could be used for new research into which microbiome compositions offer better conditions for liver regeneration. Physicians could then examine patients’ gut bacteria to determine whether conditions are favourable for surgery or whether it is better to wait for the microbiome to recover.” It might also be possible to influence recovery with a certain diet, said the authors.

“And conversely, physicians might also be able to examine the microbiome through stool samples to determine how well the liver is regenerating after an operation,” said Prof Janssen. This question will be the subject of further studies by the team, he explained. ?

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist May 2024

Irish Pharmacist May 2024. Volume 25 | Issue 5 | May 2024. Read the latest issue of Irish Pharmacist here…

Read

OTC Update Spring 2024

Spring 2024 | Issue 1 | Volume 18. Read the latest issue of OTC Update here.

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT